公开(公告)号：US20120035214A1

公开(公告)日：2012-02-09

申请号：US13262781

申请日：2010-04-01

Applicant: Daniel J. McKay ,  Melissa Arbour ,  Renee Aspiotis ,  Austin Chen ,  Pierre-Andre Fournier ,  Michel Gallant ,  Yongxin Han ,  Helene Juteau ,  Patrick Lacombe ,  Sebastien Laliberte ,  Sophie Lauzon ,  Carmela Molinaro ,  Paul O'Shea ,  Yeeman Ramtohul ,  Daniel Simard ,  Dwight MacDonald ,  Bruce Mackay ,  Christophe Mellon ,  Krista Morley ,  Chit Tsui ,  Sarah Jennifer Dolman ,  Greg Hughes ,  Jacob Janey

Inventor： Daniel J. McKay ,  Melissa Arbour ,  Renee Aspiotis ,  Austin Chen ,  Pierre-Andre Fournier ,  Michel Gallant ,  Yongxin Han ,  Helene Juteau ,  Patrick Lacombe ,  Sebastien Laliberte ,  Sophie Lauzon ,  Carmela Molinaro ,  Paul O'Shea ,  Yeeman Ramtohul ,  Daniel Simard ,  Dwight MacDonald ,  Bruce Mackay ,  Christophe Mellon ,  Krista Morley ,  Chit Tsui ,  Sarah Jennifer Dolman ,  Greg Hughes ,  Jacob Janey

IPC: A61K31/451 ,  C07D401/04 ,  C07D401/10 ,  C07D211/26 ,  C07D211/28 ,  C07D401/12 ,  A61K31/4545 ,  A61K31/454 ,  A61P9/12 ,  A61P9/04 ,  A61P9/10 ,  A61P27/06 ,  A61P25/22 ,  A61P25/00 ,  A61P13/12 ,  C07D211/22

CPC classification number: C07D211/26 ,  C07D211/22 ,  C07D211/28 ,  C07D211/52 ,  C07D401/04 ,  C07D401/12 ,  C07D413/04 ,  C07D413/14

Abstract: The present invention relates to biaryl piperidine-based renin inhibitor compounds, and their use in treating cardiovascular events and renal insufficiency.

Abstract translation: 本发明涉及联芳基哌啶基肾素抑制剂化合物及其在治疗心血管事件和肾功能不全中的用途。

公开(公告)号：US20110178115A1

公开(公告)日：2011-07-21

申请号：US13120067

申请日：2009-09-17

Applicant: Yves Leblanc ,  Carl Berthelette ,  Daniel Simard ,  Mohamed Helmi Zaghdane

Inventor： Yves Leblanc ,  Carl Berthelette ,  Daniel Simard ,  Mohamed Helmi Zaghdane

IPC: C07D471/04 ,  A61K31/4353

CPC classification number: C07D471/14

Abstract: Compounds of formula I are antagonists of the PGD2 receptor, CRTH2, and as such are useful in the treatment and/or prevention of CRTH2-mediated diseases such as asthma.

Abstract translation: 式I化合物是PGD2受体CRTH2的拮抗剂，因此可用于治疗和/或预防CRTH2介导的疾病如哮喘。

公开(公告)号：US07059384B2

公开(公告)日：2006-06-13

申请号：US10170427

申请日：2002-06-14

Applicant: Dominique Bouchard ,  Jean-Paul Nadeau ,  Francois Hamel ,  Daniel Simard ,  Serge F. Turcotte

Inventor： Dominique Bouchard ,  Jean-Paul Nadeau ,  Francois Hamel ,  Daniel Simard ,  Serge F. Turcotte

IPC: B22D11/00

CPC classification number: B22D11/06 ,  B22D11/068 ,  B22D11/124

Abstract: Disclosed is a method and apparatus for continuously casting a metal strip. A casting pool of molten metal is formed, and a metal strip is solidified onto a casting surface. The temperature of the casting surface is maintained above a predetermined critical value. By maintaining the surface temperature above the predetermined critical value, either the heat transfer uniformity or the heat transfer capacity or both are improved.

公开(公告)号：US08546422B2

公开(公告)日：2013-10-01

申请号：US13120067

申请日：2009-09-17

Applicant: Yves Leblanc ,  Carl Berthelette ,  Daniel Simard ,  Mohamed Helmi Zaghdane

Inventor： Yves Leblanc ,  Carl Berthelette ,  Daniel Simard ,  Mohamed Helmi Zaghdane

IPC: C07D491/00 ,  C07D498/00 ,  C07D513/00 ,  C07D515/00 ,  C07D471/00

CPC classification number: C07D471/14

Abstract: Compounds of formula I are antagonists of the PGD2 receptor, CRTH2, and as such are useful in the treatment and/or prevention of CRTH2-mediated diseases such as asthma.

Abstract translation: 式I化合物是PGD2受体CRTH2的拮抗剂，因此可用于治疗和/或预防CRTH2介导的疾病如哮喘。

公开(公告)号：US20070161643A1

公开(公告)日：2007-07-12

申请号：US10597720

申请日：2005-02-02

Applicant: Malken Bayrakdarian ,  Kristina Berggren ,  Ojvind Davidsson ,  Ola Fjellstrom ,  David Gustafsson ,  Stephen Hanessian ,  Tord Inghardt ,  Ingemar Nilsson ,  Mats Nagard ,  Daniel Simard ,  Eric Therrien

Inventor： Malken Bayrakdarian ,  Kristina Berggren ,  Ojvind Davidsson ,  Ola Fjellstrom ,  David Gustafsson ,  Stephen Hanessian ,  Tord Inghardt ,  Ingemar Nilsson ,  Mats Nagard ,  Daniel Simard ,  Eric Therrien

IPC: A61K31/513 ,  C07D487/02

CPC classification number: C07D413/12 ,  C07D211/98 ,  C07D401/12 ,  C07D401/14 ,  C07D413/14 ,  C07D417/12 ,  C07D417/14

Abstract: There is provided a compound of formula I wherein the dashed line, R1, R2, R3a, R3b, A, D, E, G and L have meanings given in the description, which compounds are useful as, or are useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is beneficial (e.g. conditions, such as thrombo-embolisms, where inhibition of thrombin is required or desired, and/or conditions where anticoagulant therapy is indicated).

Abstract translation: 提供式I化合物，其中虚线R 1，R 2，R 3，R 3，R 3， SUP，A，D，E，G和L具有在说明书中给出的含义，哪些化合物可用作或用作胰蛋白酶样蛋白酶的竞争性抑制剂例如凝血酶的前药，因此，特别地， 在治疗凝血酶抑制有益的条件（例如需要或期望抑制凝血酶的条件，如血栓栓塞，和/或表示抗凝治疗的条件）。